Patient assistance Actemra(tocilizumab) is a member of the interleukin inhibitors drug class and is commonly used for COVID-19, Cytokine Release Syndrome, Giant Cell Arteritis, and others. The cost for Actemra (20 mg/mL) intravenous solution is around $569 for a supply of 4 milliliters, dep...
XOLAIR® (omalizumab) for subcutaneous use ZELBORAF® (vemurafenib) Oncology Ophthalmology Rheumatology ACTEMRA® (tocilizumab) ALECENSA® (alectinib) Avastin® (bevacizumab) COLUMVI™ (glofitamab-gxbm) COTELLIC® (cobimetinib) ENSPRYNG® (satralizumab-mwge) Erivedge® (vismodeg...